NCT04412720

Brief Summary

Many studies have reported the benefits of aerobic and breathing exercises such as, reduction of symptoms and reduced the use of medications, the number of crises, exercise induced bronchoconstriction (EIB), and improvement in health-related quality of life (HRQoL). This study will be a randomized and controlled trial (RCT) with 2 parallel arms and blinded assessment. Fifty-four moderate or severe patients with asthma under optimized medication will be randomly assigned (computer-generated) into either aerobic+breathing exercises (AB) or aerobic+stretching exercises (AS). All patients will receive the same educational session and will perform the physical exercise proposed for the group for 12 weeks, 2 times/week, 60-minute sessions; however, the AB group will perform Buteyko breathing technique and AS will perform muscle stretching exercise. All patients will be assessed to clinical control, quality of life, psychosocial symptoms, pulmonary function, functional capacity, physical activity levels, sleep quality, thoracoabdominal mechanics, hyperventilation symptoms, and asthma exacerbation. The data normality will be analyzed by Kolmogorov-Smirnov. The variables obtained before interventions will be compared using the t-test or Mann-Whitney U-test. Comparisons of the outcomes initial and final data will be analyzed with repeated measures ANOVA with appropriate post hoc test. The significance level will be set to 5% for all tests.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable asthma

Timeline
Completed

Started Mar 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 5, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 21, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

June 2, 2020

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2021

Completed
Last Updated

August 24, 2023

Status Verified

January 1, 2020

Enrollment Period

11 months

First QC Date

May 21, 2020

Last Update Submit

August 22, 2023

Conditions

Keywords

Aerobic exercisesRespiratory exercisesAsthma clinical control

Outcome Measures

Primary Outcomes (1)

  • Change in asthma clinical control

    Clinical control will be evaluated by the Asthma Control Questionnaire (ACQ). The ACQ contains 7 items rated on a 7-point scale (0 = without limitation, 6 = maximum limitation), with a higher score indicating worse control. Scores lower than 0.75 are associated with good asthma control, whereas scores greater than 1.5 are indicative of poorly controlled asthma, and a change of at least 0.5 points in the ACQ score is regarded as clinically significant.

    Change from baseline to 10 weeks of intervention

Secondary Outcomes (10)

  • Change in health related quality of life

    Change from baseline to 10 weeks of intervention

  • Change in psychosocial symptoms

    Change from baseline to 10 weeks of intervention

  • Change in pulmonary function in absolute values

    Change from baseline to 10 weeks of intervention

  • Change in pulmonary function in predict values

    Change from baseline to 10 weeks of intervention

  • Change in functional capacity

    Change from baseline to 10 weeks of intervention

  • +5 more secondary outcomes

Study Arms (2)

Aerobic and Breathing Exercises

EXPERIMENTAL

The experimental intervention will be aerobic and breathing exercises.

Other: Aerobic and Breathing Exercises

Aerobic and Stretching Exercises

ACTIVE COMPARATOR

The active comparative intervention will be aerobic and stretching exercises.

Other: Aerobic and Stretching Exercises

Interventions

Aerobic exercises will be performed on a treadmill, twice a week, totaling 20 sessions of 60 minutes each. The initial intensity will be 50% to 60% of maximum heart rate and the progression will take place according to the level of effort (Borg) in the last two sessions. In addition, following the aerobic training, Buteyko Breathing Technique also will be performed during 20 minutes each exercise, in the same treatment session. During the first two weeks, the patient will learn the technique supervised by a physical therapist. In addition, the patients will receive a breathing exercise booklet for in-home training. Before and after each session, patients will be evaluated in relation to blood pressure, heart rate, oxygen saturation and asthma symptoms.

Aerobic and Breathing Exercises

Aerobic exercises will be performed on a treadmill, twice a week, totaling 20 sessions of 60 minutes each. The initial intensity will be 50% to 60% of maximum heart rate and the progression will take place according to the level of effort (Borg) in the last two sessions. In addition, following the aerobic training, stretching exercises will be performing for major muscle groups, during 30 seconds each one. The patients will receive a stretching exercise booklet for in-home training.

Aerobic and Stretching Exercises

Eligibility Criteria

Age18 Years - 59 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Asthma moderate and severe with diagnosed according to the Global Initiative for Asthma (GINA) 2020
  • Sedentary (\< 150 min of moderate to vigorous physical activity/week)
  • Body Mass Index ≥18.5 kg/m2 and \<35 kg/m2
  • Medical treatment, for at least 6 months
  • Clinically stable (i.e., no exacerbation or changes in medication for at least 30 days)

You may not qualify if:

  • Cardiovascular, musculoskeletal or other chronic lung diseases
  • Active Cancer
  • Pregnant
  • Uncontrolled hypertension or diabetes
  • Current smoker or ex smoker (\>10 pack-years)
  • Psychiatric disease or cognitive deficit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Celso Ricardo Fernandes de Carvalho

São Paulo, 01246903, Brazil

Location

MeSH Terms

Conditions

Asthma

Interventions

Breathing Exercises

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsExercise Movement TechniquesPhysical Therapy Modalities

Study Officials

  • Celso RF Carvalho, PhD

    University of Sao Paulo General Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
All the measurements will be performed by a professional blinded to the groups. The same assessor will be maintained to perform the evaluations before and after the intervention. The professionals involved with the evaluations will be different from the professionals involved on the intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 21, 2020

First Posted

June 2, 2020

Study Start

March 5, 2020

Primary Completion

January 31, 2021

Study Completion

July 31, 2021

Last Updated

August 24, 2023

Record last verified: 2020-01

Locations